Search clinical trials for: Antibiotics, Antineoplastic

Total 66341 results

Sheba Medical Center
Race Oncology Ltd

Completed

Bisantrene for Relapsed /Refractory AML

Acute Myelogenous Leukemia | Allogeneic Stem Cell Transplantation

Israel
National Cancer Institute (NCI)

Completed

FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Lymphoma

United States
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

FR901228 in Treating Patients With Hematologic Cancer

Lymphoma | Leukemia

United States
Royal Marsden NHS Foundation Trust

Unknown

A Multicenter, Open-Label Continuation Trial Evaluating the Tolerability and Activity of Depsipeptide (FK228) in Patients That Have Completed a Prior Clinical Study With Depsipeptide.

Peripheral T Cell Lymphoma (PTCL)
Assistance Publique - Hôpitaux de Paris

Completed

Antibiotic Education for Children in an Emergency Care Unit (ACHEEN)

Respiratory Tract Infections | Otorhinolaryngologic Diseases | Urinary Tract Infections | Pyelonephritis

France
Klein, Jeffrey A., M.D.

Completed

Tumescent Antibiotic Delivery Pharmacokinetics

Prevention of Surgical Site Infections

United States
Erasmus Medical Center
Centre for Human Drug Research, Netherlands

Active, not recruiting

Bleomycin Jet Injections in Keloids

Keloid

Netherlands
National Cancer Institute (NCI)

Terminated

Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma

Neoplasms | Mycosis Fungoides | Cutaneous T-Cell Lymphoma

United States
Callisto Pharmaceuticals

Terminated

Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML

Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia

United States
Boehringer Ingelheim

Terminated

Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors

Head and Neck Neoplasms
University of Colorado, Denver

Withdrawn

Fever and Neutropenia in Pediatric Oncology Patients

Neutropenia | Fever

United States
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Recruiting

Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer (Elechtra)

Vulvar Cancer

Italy
Moleculin Biotech, Inc.

Completed

Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)

Leukemia, Myeloid, Acute

Poland
Moleculin Biotech, Inc.

Completed

Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)

Leukemia, Myeloid, Acute

United States
Mayo Clinic
Roche Pharma AG

Terminated

A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors

Kidney Transplantation | Delayed Graft Function

United States
Genovate Biotechnology Co., Ltd.,
Novartis

Unknown

Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study

Uveitis

Taiwan
Medical University of South Carolina
Hoffmann-La Roche

Terminated

Mycophenolate for Pulmonary Sarcoidosis

Pulmonary Sarcoidosis

United States
University of Florida
Novartis

Completed

Desensitization of Renal Transplant Candidates

End Stage Renal Disease | Kidney Transplantation

United States
McGill University Health Centre/Research Institute...
Novartis

Unknown

Myfortic in Heart Transplant Patients With Gastrointestinal (GI) Symptoms

Heart Transplant Patients

Canada
Wake Forest University Health Sciences

Terminated

Safety and Outcomes Associated With Continuous Versus Intermittent Infusion Vancomycin

Infection

United States
Children's Hospital Medical Center, Cincinnati

Withdrawn

Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis (PRUNE)

Lupus Nephritis
Novartis

Completed

Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant

Kidney Transplantation

Brazil
Emory University

Terminated

Outcomes in Pediatric Heart Transplant Recipients Receiving Cellcept

Cardiac Transplantation

United States
University Hospital, Limoges
Hoffmann-La Roche

Unknown

Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant Recipients

Kidney Transplant Recipients

France
South Tees Hospitals NHS Foundation Trust
Teesside University

Recruiting

Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study (BEST)

Vascular Malformations

United Kingdom
Celgene

Completed

A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma

Peripheral T-cell Lymphoma

United States, Spain, Germany, France, Czechia, Australia, Sweden, United Kingdom, Ukraine, Poland
Celgene
Celgene Corporation

Completed

A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)

Cutaneous T-cell Lymphoma

United States, France, Germany, Poland, Russian Federation, United Kingdom
Universita di Verona
IGEA

Terminated

Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer

Pancreatic Cancer

Italy
Jennifer Amengual
Columbia University

Withdrawn

Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL

Lymphoma, T-Cell, Peripheral
Boehringer Ingelheim

Terminated

Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients

Head and Neck Neoplasms
Copenhagen University Hospital at Herlev
Rigshospitalet, Denmark; Glostrup University Hospital, Copenhagen

Terminated

Electrochemotherapy as a Palliative Treatment for Brain Metastases

Brain Metastases | CNS Metastases

Denmark
Southwest Oncology Group
National Cancer Institute (NCI)

Terminated

S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral Cancer
Seoul National University Hospital
National Institute of Food and Drug Safety Evaluation (Republic of Korea)

Recruiting

Pharmacokinetics and Pharmacodynamics of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation

Korea, Republic of
Chulalongkorn University
Berlin Pharmaceutical Industry

Terminated

Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis

Lupus Nephritis

Thailand
Columbia University

Completed

Study of CellCept for Advanced Pancreatic Cancer

Pancreatic Cancer

United States
King Faisal Specialist Hospital & Research Center

Unknown

Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Saudi Arabia
Clinical Hospital Merkur
University Hospital Rijeka; University Medical Centre Ljubljana

Completed

Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis

Kidney Transplantation | Kidney Failure

Croatia
Novartis Pharmaceuticals

Completed

Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients

Kidney Transplantation

France, Germany, United Kingdom, Spain, Switzerland, United States, Canada, Italy
University of Birmingham
Celgene; Amgen; Bloodwise

Completed

Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients (RomiCar)

Peripheral T Cell Lymphoma

United Kingdom
Celgene
Celgene Corporation

Completed

A Rollover Study for Patients Who Participated in Other Romidepsin Protocols

Lymphoma | Cancer

United States, United Kingdom
Celgene

Completed

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

Carcinoma, Renal Cell | Prostatic Neoplasms

United States, United Kingdom
Celgene

Completed

A Research Study for Patients With Metastatic Renal Cell Carcinoma

Carcinoma, Renal Cell | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma

Lymphoma

United States
Fondation Hôpital Saint-Joseph

Recruiting

Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient? (COPROBLSE2)

Enterobacteria Infections

France
Makerere University

Completed

Single Dose Ceftriaxone and Metronidazole Versus Multiple Doses for Antibiotic Prophylaxis at Elective Cesarean Section. (SDvMD)

Post Operative Infections

Uganda
PharmAthene, Inc.
Quintiles, Inc.; National Institutes of Health (NIH); Department of Health and... and other collaborators

Terminated

Ph1 Study of Valortim and Doxycycline in Humans

Anthrax

United States
Pfizer

Completed

InO - A Retrospective Study of UK Patients With Leukaemia (InO)

Precursor Cell Lymphoblastic Leukemia-Lymphoma

United Kingdom
Jennifer Amengual

Completed

Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies (PDX+Romi)

Lymphoma | Multiple Myeloma | Hodgkin Lymphoma | Lymphoid Malignancies | Non-hodgkin Lymphoma

United States
National Cancer Institute (NCI)

Completed

Depsipeptide to Treat Thyroid and Other Advanced Cancers

Neoplasms

United States

Search clinical trials for: Antibiotics, Antineoplastic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations